{"title":"[Titration strategy of sacubitril/valsartan in patients with heart failure with reduced ejection fraction and hypotension].","authors":"A H Wu, Z W Lin, X P Ji, H X Lyu","doi":"10.3760/cma.j.cn112148-20221222-01006","DOIUrl":null,"url":null,"abstract":"沙库巴曲缬沙坦作为一种新型的血管紧张素受体脑啡肽酶抑制剂，已经成为射血分数降低的心力衰竭（HFrEF）患者的一线用药，同时，沙库巴曲缬沙坦也具有降压作用，所以，目前对于合并低血压的HFrEF（HFrEF-LSBP）患者能否从沙库巴曲缬沙坦中获益存在争议。该文对低血压对沙库巴曲缬沙坦滴定的影响进行综述，并提出了HFrEF-LSBP患者中滴定沙库巴曲缬沙坦的策略，为该类患者的治疗提供参考。.","PeriodicalId":38755,"journal":{"name":"中华心血管病杂志","volume":"51 10","pages":"1098-1103"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华心血管病杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112148-20221222-01006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
中华心血管病杂志Medicine-Cardiology and Cardiovascular Medicine
CiteScore
1.40
自引率
0.00%
发文量
10577
期刊介绍：
The Chinese Journal of Cardiology , established in February 1973, is one of the major academic medical journals sponsored by the Chinese Medical Association and a leading periodical in the field of cardiology in China. It specializes in cardiology and related disciplines with a readership of more than 25 000. The journal publishes editorials and guidelines as well as important original articles on clinical and experimental investigations, reflecting achievements made in China and promoting academic communication between domestic and foreign cardiologists. The journal includes the following columns: Editorials, Strategies, Comments, Clinical Investigations, Experimental Investigations, Epidemiology and Prevention, Lectures, Comprehensive Reviews, Continuing Medical Education, etc.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
